X4 PHARMACEUTICALS, INC Increase (Decrease) in Accounts Payable
X4 PHARMACEUTICALS, INC (XFOR) reported Increase (Decrease) in Accounts Payable of -$1.76 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-06
- X4 PHARMACEUTICALS, INC increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$1.14M.
- X4 PHARMACEUTICALS, INC increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$624.00K, a 125.20% decline year-over-year.
- X4 PHARMACEUTICALS, INC increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $642.00K, a 723.08% increase year-over-year.
- X4 PHARMACEUTICALS, INC increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$2.65M, a 557.59% decline year-over-year.
- X4 PHARMACEUTICALS, INC increase (decrease) in accounts payable for fiscal 2025 was -$2.98M.
- X4 PHARMACEUTICALS, INC increase (decrease) in accounts payable for fiscal 2024 was -$286.00K, a 123.18% decline from fiscal 2023.
- X4 PHARMACEUTICALS, INC increase (decrease) in accounts payable for fiscal 2023 was $1.23M, a 63.97% decline from fiscal 2022.
- X4 PHARMACEUTICALS, INC increase (decrease) in accounts payable for fiscal 2022 was $3.42M, a 193.74% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 3 month as first filed | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 6 month as first filed | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 9 month as first filed | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.76M 10-Q · filed 2026-08-06 | -$1.12M derived: sum of 3 quarters · filed 2026-08-06 | -$3.78M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$624.00K 10-Q · filed 2026-05-06 | $18.00K derived: sum of 2 quarters · filed 2026-05-06 | -$2.64M derived: sum of 3 quarters · filed 2026-05-06 | -$6.08M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $642.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | -$2.01M derived: sum of 2 quarters · filed 2026-03-17 | -$5.46M derived: sum of 3 quarters · filed 2026-08-06 | -$2.98M 10-K · filed 2026-03-17 | ||||
| 2025-09-30 | -$2.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$6.10M derived: sum of 2 quarters · filed 2026-08-06 | -$3.62M 10-Q · filed 2025-11-05 | -$3.54M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$3.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$967.00K 10-Q · filed 2026-08-06 | -$889.00K derived: sum of 3 quarters · filed 2026-08-06 | -$309.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $2.48M 10-Q · filed 2026-05-06 | $2.55M derived: sum of 2 quarters · filed 2026-05-06 | $3.13M derived: sum of 3 quarters · filed 2026-05-06 | $2.19M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $78.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $658.00K derived: sum of 2 quarters · filed 2026-03-17 | -$290.00K derived: sum of 3 quarters · filed 2026-03-17 | -$286.00K 10-K · filed 2026-03-17 | ||||
| 2024-09-30 | $580.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$368.00K derived: sum of 2 quarters · filed 2025-11-05 | -$364.00K 10-Q · filed 2025-11-05 | $444.00K derived: sum of 4 quarters · filed 2026-03-17 | ||||
| 2024-06-30 | -$948.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$944.00K 10-Q · filed 2025-08-08 | -$136.00K derived: sum of 3 quarters · filed 2026-03-17 | $3.10M derived: sum of 4 quarters · filed 2026-03-17 | ||||
| 2024-03-31 | $4.00K 10-Q · filed 2025-05-01 | $812.00K derived: sum of 2 quarters · filed 2026-03-17 | $4.05M derived: sum of 3 quarters · filed 2026-03-17 | $2.95M derived: sum of 4 quarters · filed 2026-03-17 | ||||
| 2023-12-31 | $808.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $4.05M derived: sum of 2 quarters · filed 2026-03-17 | $2.95M derived: sum of 3 quarters · filed 2026-03-17 | $1.23M 10-K · filed 2026-03-17 | ||||
| 2023-09-30 | $3.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $2.14M derived: sum of 2 quarters · filed 2024-11-13 | $426.00K 10-Q · filed 2024-11-13 | $4.33M derived: sum of 4 quarters · filed 2025-03-26 | ||||
| 2023-06-30 | -$1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$2.81M 10-Q · filed 2024-08-08 | $1.09M derived: sum of 3 quarters · filed 2025-03-26 | $1.22M derived: sum of 4 quarters · filed 2025-03-26 | ||||
| 2023-03-31 | -$1.71M 10-Q · filed 2024-05-07 | $2.19M derived: sum of 2 quarters · filed 2025-03-26 | $2.32M derived: sum of 3 quarters · filed 2025-03-26 | $2.42M derived: sum of 4 quarters · filed 2025-03-26 | ||||
| 2022-12-31 | $3.91M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $4.03M derived: sum of 2 quarters · filed 2025-03-26 | $4.14M derived: sum of 3 quarters · filed 2025-03-26 | $3.42M 10-K · filed 2025-03-26 | ||||
| 2022-09-30 | $124.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $232.00K derived: sum of 2 quarters · filed 2023-11-09 | -$481.00K 10-Q · filed 2023-11-09 | $1.38M derived: sum of 4 quarters · filed 2024-03-21 | ||||
| 2022-06-30 | $108.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$605.00K 10-Q · filed 2023-08-10 | $1.26M derived: sum of 3 quarters · filed 2024-03-21 | $1.15M derived: sum of 4 quarters · filed 2024-03-21 | ||||
| 2022-03-31 | -$713.00K 10-Q · filed 2023-05-04 | $1.15M derived: sum of 2 quarters · filed 2024-03-21 | $1.04M derived: sum of 3 quarters · filed 2024-03-21 | $476.00K derived: sum of 4 quarters · filed 2024-03-21 | ||||
| 2021-12-31 | $1.86M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $1.76M derived: sum of 2 quarters · filed 2024-03-21 | $1.19M derived: sum of 3 quarters · filed 2024-03-21 | $1.17M 10-K · filed 2024-03-21 | ||||
| 2021-09-30 | -$103.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$672.00K derived: sum of 2 quarters · filed 2022-11-03 | -$695.00K 10-Q · filed 2022-11-03 | $215.00K derived: sum of 4 quarters · filed 2023-03-21 | ||||
| 2021-06-30 | -$569.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$592.00K 10-Q · filed 2022-08-04 | $318.00K derived: sum of 3 quarters · filed 2023-03-21 | $650.00K derived: sum of 4 quarters · filed 2023-03-21 | ||||
| 2021-03-31 | -$23.00K 10-Q · filed 2022-05-12 | $887.00K derived: sum of 2 quarters · filed 2023-03-21 | $1.22M derived: sum of 3 quarters · filed 2023-03-21 | $1.81M derived: sum of 4 quarters · filed 2023-03-21 | ||||
| 2020-12-31 | $910.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-21 | $1.24M derived: sum of 2 quarters · filed 2023-03-21 | $1.83M derived: sum of 3 quarters · filed 2023-03-21 | $1.03M 10-K · filed 2023-03-21 | ||||
| 2020-09-30 | $332.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $921.00K derived: sum of 2 quarters · filed 2021-11-04 | $121.00K 10-Q · filed 2021-11-04 | $500.00K derived: sum of 4 quarters · filed 2022-03-17 | ||||
| 2020-06-30 | $589.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | -$211.00K 10-Q · filed 2021-08-03 | $168.00K derived: sum of 3 quarters · filed 2022-03-17 | -$1.26M derived: sum of 4 quarters · filed 2022-03-17 | ||||
| 2020-03-31 | -$800.00K 10-Q · filed 2021-05-06 | -$421.00K derived: sum of 2 quarters · filed 2022-03-17 | -$1.85M derived: sum of 3 quarters · filed 2022-03-17 | -$4.88M derived: sum of 4 quarters · filed 2022-03-17 | ||||
| 2019-12-31 | $379.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$1.05M derived: sum of 2 quarters · filed 2022-03-17 | -$4.08M derived: sum of 3 quarters · filed 2022-03-17 | -$2.75M 10-K · filed 2022-03-17 | ||||
| 2019-09-30 | -$1.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$4.46M derived: sum of 2 quarters · filed 2020-11-05 | -$3.13M 10-Q · filed 2020-11-05 | -$2.03M derived: sum of 4 quarters · filed 2021-03-19 | ||||
| 2019-06-30 | -$3.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | -$1.70M 10-Q · filed 2020-08-04 | -$604.00K derived: sum of 3 quarters · filed 2021-03-19 | $210.00K derived: sum of 4 quarters · filed 2021-03-19 | ||||
| 2019-03-31 | $1.33M 10-Q · filed 2020-05-07 | $2.43M derived: sum of 2 quarters · filed 2021-03-19 | $3.24M derived: sum of 3 quarters · filed 2021-03-19 | $3.20M derived: sum of 4 quarters · filed 2021-03-19 | ||||
| 2018-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19 | $1.91M derived: sum of 2 quarters · filed 2021-03-19 | $1.87M derived: sum of 3 quarters · filed 2021-03-19 | $1.31M 10-K · filed 2021-03-19 | -$1.34M 10-K · filed 2019-03-11 | |||
| 2018-09-30 | $814.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $772.00K derived: sum of 2 quarters · filed 2019-11-07 | $209.00K 10-Q · filed 2019-11-07 | $270.00K 10-Q · filed 2018-11-09 | -$3.30M derived: sum of 4 quarters · filed 2020-03-12 | |||
| 2018-06-30 | -$42.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$605.00K 10-Q · filed 2019-08-07 | $257.00K 10-Q · filed 2018-08-13 | -$4.12M derived: sum of 3 quarters · filed 2020-03-12 | -$1.21M derived: sum of 4 quarters · filed 2020-03-12 | |||
| 2018-03-31 | -$563.00K 10-Q · filed 2019-05-15 | -$788.00K 10-Q · filed 2018-05-10 | -$4.07M derived: sum of 2 quarters · filed 2020-03-12 | -$1.17M derived: sum of 3 quarters · filed 2020-03-12 | -$3.07M derived: sum of 4 quarters · filed 2020-03-12 | |||
| 2017-12-31 | -$3.51M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$606.00K derived: sum of 2 quarters · filed 2020-03-12 | -$2.51M derived: sum of 3 quarters · filed 2020-03-12 | -$1.17M 10-K · filed 2020-03-12 | $182.00K 10-K · filed 2019-03-11 | |||
| 2017-09-30 | $2.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $1.00M derived: sum of 2 quarters · filed 2018-11-09 | $2.34M 10-Q · filed 2018-11-09 | |||||
| 2017-06-30 | -$1.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | -$563.00K 10-Q · filed 2018-08-13 | ||||||
| 2017-03-31 | $1.34M 10-Q · filed 2018-05-10 | |||||||
| 2016-12-31 | $1.26M 10-K · filed 2019-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |